Das gemeinnützige SRH Zentralklinikum Suhl ist ein Akutkrankenhaus in Südthüringen mit 24 eigenständigen Fach- und Teilgebieten der Medizin und 519 Planbetten mit überregionalem Versorgungsauftrag. 2017 wurden 80.650 Patienten ambulant und 33.965 stationär behandelt.

During the past decade, SRH Zentralklinikum Suhl conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 2 clinical trials were completed, i.e. on average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "SRH Zentralklinikum Suhl" #1 sponsor was "Biotronik SE & Co. KG" with 2 trials, followed by "A. M. Zeiher" with 1 trials sponsored, "AGO Research GmbH" with 1 trials sponsored, "Biotronik AG" with 1 trials sponsored and "Boston Scientific Corporation" with 1 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "SRH Zentralklinikum Suhl" #1 collaborator was "ARCAGY/ GINECO GROUP" with 1 trials as a collaborator, "Abbott Medical Devices" with 1 trials as a collaborator, "Amgen" with 1 trials as a collaborator, "Arbeitsgemeinschaft Gynaekologische Onkologie Austria" with 1 trials as a collaborator and "AstraZeneca" with 1 trials as a collaborator. Other collaborators include 13 different institutions and companies that were collaborators in the rest 23 trials.

According to Clinical.Site data, the most researched conditions in "SRH Zentralklinikum Suhl" are "Heart Failure" (3 trials), "Breast Neoplasms" (2 trials), "Myocardial Infarction" (2 trials), "Brain Ischemia With Non-valvular Atrial Fibrillation" (1 trials) and "Breast Cancer" (1 trials). Many other conditions were trialed in "SRH Zentralklinikum Suhl" in a lesser frequency.

Most popular intervention types in "SRH Zentralklinikum Suhl" are "Device" (6 trials), "Drug" (6 trials), "Biological" (3 trials), "Behavioral" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (2 trials), "Letrozole" (2 trials), "ABSORB Scaffold" (1 trials), "Acticor/Rivacor ICDs/CRT-Ds" (1 trials) and "Anastrozole" (1 trials). Other intervention names were less common.

The vast majority of trials in "SRH Zentralklinikum Suhl" are 15 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "SRH Zentralklinikum Suhl". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in SRH Zentralklinikum Suhl, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in SRH Zentralklinikum Suhl, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".